跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROHANCE gadoteridol 2793mg/10mL injection syringe - TGA Drug Approval Details
Approvals
/
TGA
/
PROHANCE gadoteridol 2793mg/10mL injection syringe
Approved
STANDARD
PROHANCE gadoteridol 2793mg/10mL injection syringe
Bracco Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e7eb9c06e027cec4
Company
Bracco Pty Ltd
Type
Standard
Approval Details
Approval Id
e7eb9c06e027cec4
Product Name
PROHANCE gadoteridol 2793mg/10mL injection syringe
Artg Id
72674
Artg Name
PROHANCE gadoteridol 2793mg/10mL injection syringe
Sponsor
Bracco Pty Ltd
Company Detail Path
/organization/c-and-r-bracco-pty-ltd
Artg Date
2000-09-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-01297-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-02764-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e7eb9c06e027cec4
Type
Standard
Back to TGA Approvals